STERNBERG HAL 4
4 · AgeX Therapeutics, Inc. · Filed Mar 13, 2019
Insider Transaction Report
Form 4
STERNBERG HAL
Vice President-Research
Transactions
- Award
Option to Purchase Common Stock
2019-03-11+15,000→ 15,000 totalExercise: $4.28Exp: 2029-03-10→ Common Stock (15,000 underlying)
Holdings
- 133
Common Stock, $0.0001 par value
Footnotes (2)
- [F1]Shares acquired in a distribution exempt from Section 16 of the Securities Exchange Act of 1934 pursuant to Rule 16a-9.
- [F2]One quarter shall vest on March 11, 2020 and the remaining shall vest monthly over 36 months, based upon continuous service.